Serum and uterine concentrations of cefazolin, cefuroxime, and ceftriaxone after intraoperative prophylactic administration during cesarean section

Journal of Pelvic Medicine and Surgery

Volumn 13, Issue 6, 2007, Pages 361-365

  Jankovic, Slobodan M ^a   Varjacic, Mirjana ^b   Crnogorac, Snezana ^c  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b Clinical Center   (Serbia)

^c Clinical Center   (Montenegro)

Author keywords

Antibiotic prophylaxis; Cefazolin; Cesarean section; Surgical site infection

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; GALECEF; NILACEF; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG TISSUE LEVEL; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SURGICAL INFECTION; UMBILICAL CORD; UTERUS CAVITY;

EID: 37349047788     PISSN: 15425983     EISSN: None     Source Type: Journal    
DOI: 10.1097/SPV.0b013e31815a4479     Document Type: Article

References (18)

1. Smaill F, Hofmeyr GJ. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev. 2002;(3):CD000933.
2. Guidelines for the use of prophylactic antibiotics in surgery in Taiwan. J Microbiol Immunol Infect. 2004;37:71-74.
3. Munckhof W. Antibiotics for surgical prophylaxis. Aust Prescriber. 2005;28:38-40.
4. Petersen EE, Daschner FD, Pelz K, et al. Antibiotic prevention in hysterectomy. Effectivity of a single preoperative ceftriaxon dose. Geburtshilfe Frauenheilkd. 1983;43:492-497.
5. Thigpen BD, Hood WA, Chauhan S, et al. Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial. Am J Obstet Gynecol. 2005;192:1864-1868.
6. Hongo M, Shimizu R, Hayashi S, et al. Study on transfer of T-1982 (cefbuperazone) into female genital organs. Jpn J Antibiot. 1983;36:1033-1040.
7. Craft I, Mullinger BM, Kennedy MR. Placental transfer of cefuroxime. Br J Obstet Gynaecol. 1981;88:141-145.
8. Fiore Mitchell T, Pearlman MD, Chapman RL, et al. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol. 2001;98:1075-1079.
9. Jankovic SM, Ninkovic V. Monitoring of serum concentrations of antibiotics by microbiological method: a one year experience. Med Pregl. 1998;51:333-342.
10. Moir-Bussy BR, Hutton RM, Thompson JR. Wound infection after caesarean section. J Hosp Infect. 1984;5:359-370.
11. Kasatpibal N, Jamulitrat S, Chongsuvivatwong V. Standardized incidence rates of surgical site infection: a multicenter study in Thailand. Am J Infect Control. 2005;33:587-594.
12. Barbut F, Carbonne B, Truchot F, et al. Surgical site infections after cesarean section: results of a five-year prospective surveillance. J Gynecol Obstet Biol Reprod. 2004;33:487-496.
13. Perry TR, Schentag JJ. Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding. Clin Pharmacokinet. 2001;40:685-694.
14. Alfter G, Schwenzer N, Friess D, et al. Perioperative antibiotic prophylaxis with cefuroxime in oral-maxillofacial surgical procedures. J Craniomaxillofac Surg. 1995;23:38-41.
15. Kaukonen JP, Tuomainen P, Makijarvi J, et al. Intravenous cefuroxime prophylaxis. Tissue levels after one 3-gram dose in 40 cases of hip fracture. Acta Orthop Scand. 1995;66:14-16.
16. Edmiston CE, Krepel C, Kelly H, et al. Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? Surgery. 2004;136:738-747.
17. Zhou M, Chen L. Study of high-risk factors of surgical site infection after cesarean section Di Yi Jun Yi Da Xue Xue Bao. 2005;25:1075-1078.
18. McEniry DW, Gorbach SL. Cephalosporins in surgery. Prophylaxis and therapy. Drugs. 1987;34(suppl 2):216-239.